Schedule 13G ownership disclosure

Immune Design Corp.

Security class unavailable · CUSIP: 45252L103

Event date: 2016-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,735,405
Percent of class
6.8300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001040188-17-000020
Form type
SC 13G/A
Filer
IMMUNE DESIGN CORP.
CIK
CIK 1437786
Filed
Feb 10, 2017
Reporting period
Dec 31, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub